Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 June 2019 | Story Rulanzen Martin | Photo Tania Allen
Jerry Mofokeng, Prof Francis Petersen and Prof Nico Luwes
Dr Jerry Mofokeng Wa Makhetha, Prof Francis Petersen and Prof Nico Luwes at a luncheon hosted by the UFS Chancellor, Dr Khotso Mokhele.

WATCH: Livestream


Dr Jerrry Mofokeng Wa Makhetha received an honorary Doctor of Letters (DLitt) degree for his commitment to scholarship and his service to humanity, from the University of the Free State (UFS) on 28 June 2019, during the second last ceremony of the 2019 June Graduations.

“This award will bring credit and honour to the university and endorse his exceptional dedication to the promotion of art, the values and reputation he exhibited in his outstanding career as both a creative artist and as an arts manager,” says Prof Nico Luwes, Head of the UFS Department of Drama and Theatre Arts


Fugard’s The Island a ‘thank you’

For this exceptional honour, Dr Mofokeng, together with Master’s student Charl Henning, agreed to direct and produce Athol Fugard’s play The Island for the Department of Drama and Theatre Arts. “As a sign of goodwill from his side, he decided to offer his talents and direct the play with our department,” says Prof Luwes. 

“Is there a way of linking the theme of The Island with the ethos of the UFS? For me the one aspect that stands out, is the celebration of languages,” says Dr Mofokeng. The play is in the three primary languages of the Free State: English, Sesotho and Afrikaans. Only graduates from the department will be cast, which according to Mofokeng, will “give a professional credence to the training of the department”. 

The play was performed on 27 June 2019 in the Scaena Theatre on the UFS Bloemfontein Campus, and on 1,2 and 6 July 2019 during the Free State Arts Festival also in the kykNet-Scaena Theatre.

Acclaimed actor, academic and writer 

Dr Mofokeng is a world-renowned, respected television and theatre actor. He is also a film writer, academic, and National Arts Administrator. He studied drama at the University of the Witwatersrand and obtained a Master’s Degree in theatre directing at Columbia University in the US. Mofokeng has also starred in a slew of movies and television shows   most notably in the 2005 Academy Award winner for Best Foreign Film, Tsotsi. He is currently appearing  on the small screen as Neo Mokgethi (Bra Moscow) in e.tv’s Scandal. 





News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept